v3.25.4
Common Stock and Stock Compensation - Additional Information (Detail)
12 Months Ended
May 20, 2025
$ / shares
shares
Apr. 28, 2025
$ / shares
shares
Mar. 20, 2025
$ / shares
shares
Mar. 06, 2025
$ / shares
shares
Feb. 19, 2025
$ / shares
shares
Dec. 20, 2017
USD ($)
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
Installment
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of common stock, authorized             1,000,000,000 1,000,000,000  
Number of preferred stock, authorized             10,000,000    
Common stock, par value | $ / shares             $ 0.01 $ 0.01  
Preferred stock, par value | $ / shares             $ 0.01    
Preferred stock, shares issued             0    
Preferred stock, shares outstanding             0    
Aggregated cash dividends paid | $             $ 190,000,000 $ 108,000,000 $ 79,000,000
Stock-based compensation expense | $             67,000,000 70,000,000 66,000,000
Income tax benefit (expense) recognized | $             $ (1,000,000) $ 2,000,000 $ 7,000,000
Earlier authorized shares under stock based compensation | shares             69,400,000    
Duration of performance-based restricted stock awards, vested             Options granted under our stock-based compensation plans generally vest over a three-year period starting one year from the date of grant and expire ten years from the date of grant.    
Weighted average grant-date fair value of options | $ / shares             $ 6.67 $ 7.9 $ 9.75
Total intrinsic value of options exercised | $             $ 0 $ 1,000,000  
Stock option, Minimum Range | $ / shares             $ 15.00    
Stock option, Maximum Range | $ / shares             $ 38.86    
Weighted-average remaining contractual term for outstanding stock options             3 years 4 months 9 days    
Weighted-average remaining contractual term for exercisable stock options             2 years 9 months 14 days    
Aggregate intrinsic value of outstanding options | $             $ 0    
Total unrecognized compensation cost related to nonvested stock options | $             $ 6,000,000    
Compensation cost not yet recognized, period for recognition             3 years    
Total fair value of stock options vested | $             $ 9,000,000 9,000,000 $ 9,000,000
Cash received from option exercises | $             0 3,000,000 4,000,000
Actual tax benefit (expense) from share based compensation | $             0 0 $ 0
Cash payment of stock appreciation rights | $             $ 315,000,000 $ 229,000,000  
Stock options granted             526,425 1,110,478 1,014,002
Weighted average exercise price per share of options | $ / shares             $ 15.28 $ 17.52 $ 21.76
Stock Appreciation Rights (SARs)                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock appreciation rights exchange percentage           94.75%      
Cash payment of stock appreciation rights | $           $ 14,000,000      
Cash paid to settle SARs | $             $ 0    
Compensation cost recognized | $             $ 0 $ 0 $ 0
Employee Stock Option                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Weighted average grant-date fair value of options | $ / shares           $ 8.47      
Stock options granted           3,613,707      
Weighted average exercise price per share of options | $ / shares           $ 34.32      
Restricted Stock Units [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Duration of performance-based restricted stock awards, vested             The RSUs vest in three equal annual installments commencing on the first anniversary of the grant date.    
Shares granted     82,781 750 3,214,507        
Restricted stock granted fair value | $ / shares     $ 15.1 $ 14.35 $ 15.28        
Number of equal annual vesting installments | Installment               3  
Restricted Stock Units and Performance Share Awards [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Total unrecognized compensation cost related to nonvested stock options | $             $ 68,000,000    
Compensation cost not yet recognized, period for recognition             2 years    
Shares granted             4,112,266 3,204,434 2,792,465
Restricted stock granted fair value | $ / shares             $ 16.02 $ 17.96 $ 22.70
Performance-base restricted stock [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Description of performance goal             The 2025 PSAs can be earned based on performance against two established goals over a three-year period    
Performance-base restricted stock [Member] | Senior Management Employees [Member] | Minimum [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares granted     0   0        
Performance-base restricted stock [Member] | Senior Management Employees [Member] | Maximum [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares granted     152,316   1,217,278        
TSR Award [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Description of performance goal             85% with a TSR (total shareholder return) goal and 15% with an internal NVA (“NOV Value Added”, a return on capital metric) goal. TSR performance is determined by comparing the Company’s TSR with the TSR of the members of the Philadelphia Stock Exchange’s Oil Services Sector Index (OSX) for the three-year performance period. The TSR portion of the performance share awards is subject to a vesting cap equal to 100% of Target Level if the Company’s absolute TSR is negative, regardless of relative TSR results. Conversely, if the Company’s absolute TSR is greater than 15% annualized over the three-year performance period the payout amount shall not be less than 50% of Target Level, regardless of relative TSR results. The NVA goal is based on the Company’s improvement in NVA from the beginning of the performance period until the end of the performance period. NVA is calculated as an amount equal to the Company’s (a) gross cash earnings less (b) average gross operating assets times an amount equal to a required return on assets, with certain adjustments.On April 28, 2025, the Company granted 1,839 restricted stock units with a fair value of $12.24 per share. The awards were granted to employees and vest in three equal annual installments commencing on the first anniversary of grant date.    
TSR [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Percentage of performance shares awarded             85.00%    
NVA [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Percentage of performance shares awarded             15.00%    
2018 Plan [Member] | Employee Stock Option                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Weighted average grant-date fair value of options | $ / shares         $ 6.67        
Stock options granted         526,425        
Weighted average exercise price per share of options | $ / shares         $ 15.28        
2018 Plan [Member] | Restricted Stock Units [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares granted 127,592 1,839              
Restricted stock granted fair value | $ / shares $ 12.54 $ 12.24              
NOV Plan [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Authorized shares under stock based compensation             70,900,000    
Remaining shares available for future grants under the Plan             17,200,000